Higgins Announces Cancer Research Grant for UB
Jan 23, 2013
Congressman Brian Higgins (NY-26) announced the University at Buffalo (UB) has been awarded a $59,031 federal grant from the National Cancer Institute (NCI).
“Cutting edge research is happening right here in Western New York with the help of talented UB scientists,” said Higgins. “Federal research dollars invested in this community are delivering better treatments, detection and advancing the ultimate goal of bringing us closer to a cure.”
Researchers will use the federal funding to develop new iron based agents to monitor tumors being treated with alkalinizing therapies, specifically the recently FDA-approved oral bicarbonate, to determine the their effectiveness. The use of these agents would ideally be a less expensive anticancer treatment that reduces metastasis and malignancy of tumors by closely modulating dosage and decreasing potential negative side effects from the use of alkalinizing therapies. The project, funded under the NCI’s Cancer Detection and Diagnosis Research program, will be overseen by UB Researcher, Dr. Janet Morrow.
Congressman Higgins is a member of the bipartisan Congressional Cancer Caucus and a vocal supporter of a substantial national investment in cancer research. He recently testified before the House of Representatives Budget Committee calling for the doubling of funding for medical research over the next 5 years.
Established by Congress in 1937, the National Cancer Institute’s primary responsibilities include coordinating the National Cancer Program; conducting and supporting cancer research; training physicians and scientists; and disseminating information about cancer detection, diagnosis, treatment, prevention, control, palliative care, and survivorship. For more information on the NCI visit: www.cancer.gov.